Picture of Rafael Holdings logo

RFL Rafael Holdings Share Price

0.000.00%
us flag iconLast trade - 00:00
FinancialsAdventurousMicro CapNeutral

Momentum

Relative Strength (%)
1m-0.07%
3m-16.08%
6m-23.81%
1yr-31.25%
Volume Change (%)
10d/3m-35%
Price vs... (%)
52w High-34.13%
50d MA-5.35%
200d MA-12.59%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-12.64%
Return on Equity2.2%
Operating Margin-4729.82%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Jul 202431st Jul 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Rafael Holdings EPS forecast chart

Profile Summary

Rafael Holdings, Inc. is a holding company with interests in clinical and early-stage pharmaceutical companies. The Company's segments include healthcare and real estate. The Company's investments include Cornerstone Pharmaceuticals, Inc., which is a cancer metabolism-based therapeutics company; LipoMedix Pharmaceuticals Ltd., which is a clinical-stage pharmaceutical company; Barer Institute Inc., which is a preclinical cancer metabolism research operation; Cyclo Therapeutics Inc., which is a clinical-stage biotechnology company dedicated to developing medicines for patients and families living with diseases through its therapeutic asset like Trappsol and Cyclo; Day Three Labs, Inc., which offers pharmaceutical-grade technology like Unlokt, and Rafael Medical Devices, LLC, which is an orthopedic-focused medical device company developing instruments to advance minimally invasive surgeries. Its real estate segment comprises of a portion of a commercial building in Israel.

Directors

Last Annual
July 31st, 2023
Last Interim
January 31st, 2024
Incorporated
July 27th, 2017
Public Since
March 12th, 2018
No. of Shareholders
263
No. of Employees
13
Sector
Real Estate Operations
Industry
Financials
Exchange
us flag iconNew York Stock Exchange
Shares in Issue
24,584,439

RFL Share Price Performance

Upcoming Events for RFL

Q3 2024 Rafael Holdings Inc Earnings Release

Similar to RFL

Picture of American Realty Investors logo

American Realty Investors

us flag iconNew York Stock Exchange

Picture of American Strategic Investment Co logo

American Strategic Investment Co

us flag iconNew York Stock Exchange

Picture of Anywhere Real Estate logo

Anywhere Real Estate

us flag iconNew York Stock Exchange

Picture of Brookfield Business Partners LP logo

Brookfield Business Partners LP

us flag iconNew York Stock Exchange

Picture of CBRE logo

CBRE

us flag iconNew York Stock Exchange

FAQ